Effect of Synaid on cognitive functions and mood in elderly subjects with self-perceived loss of memory after COVID-19 infection

INTRODUCTION: There is growing attention towards the possible long-term effect of COVID-19 on neuropsychiatric disorders. METHODS: We tested the effect of a combined nutraceutical (Synaid) with known nootropic effects in 40 elderly patients with self-perceived cognitive decline after SARS-CoV-2 infe...

Descripción completa

Detalles Bibliográficos
Autores principales: Bove, Marilisa, Fogacci, Federica, Quattrocchi, Silvia, Veronesi, Maddalena, Cicero, Arrigo F.G.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Termedia Publishing House 2021
Materias:
Research Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8641516/
https://www.ncbi.nlm.nih.gov/pubmed/34900061
http://dx.doi.org/10.5114/aoms/141502
Descripción
Sumario:INTRODUCTION: There is growing attention towards the possible long-term effect of COVID-19 on neuropsychiatric disorders. METHODS: We tested the effect of a combined nutraceutical (Synaid) with known nootropic effects in 40 elderly patients with self-perceived cognitive decline after SARS-CoV-2 infection, treated at home or in hospital. RESULTS: After 3 months of treatment, Synaid significantly improved functional status, MMSE and the main psychological disorders associated with mild cognitive impairment, both in patients previously cared for at home and in hospital because of SARS-CoV-2 infection. CONCLUSIONS: Synaid was well tolerated and effective in improving cognitive function and psychosocial parameters after SARS-CoV-2 infection.

Ejemplares similares